by dyadic | Sep 17, 2020 | Press Releases
LIANYUNGANG, CHINA and JUPITER, FL / ACCESSWIRE / September 17, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform...
by dyadic | Sep 14, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / September 14, 2020 / Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ:DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1 gene expression...
by dyadic | Aug 13, 2020 | Press Releases
Entered into two new collaborations with top tier animal health companies Entered into a fully funded human health collaboration with a top five global pharmaceutical company Started an animal trial for SARS-CoV-2 RBD vaccine candidate in Israel and another animal...
by dyadic | Jul 30, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / July 30, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower production...
by dyadic | Jul 15, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / July 15, 2020 / Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying...
